James Costello
Concepts (451)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder Neoplasms | 12 | 2024 | 258 | 2.650 |
Why?
| | Computational Biology | 12 | 2025 | 669 | 2.060 |
Why?
| | Cisplatin | 4 | 2024 | 345 | 1.490 |
Why?
| | Gene Expression Profiling | 11 | 2025 | 1767 | 1.400 |
Why?
| | Drug Resistance, Neoplasm | 8 | 2024 | 881 | 1.390 |
Why?
| | Prostatic Neoplasms | 5 | 2025 | 978 | 1.260 |
Why?
| | Algorithms | 14 | 2025 | 1845 | 1.240 |
Why?
| | Down Syndrome | 4 | 2025 | 525 | 1.170 |
Why?
| | Systems Biology | 2 | 2025 | 69 | 1.080 |
Why?
| | Antineoplastic Agents | 9 | 2024 | 2214 | 1.050 |
Why?
| | Cell Line, Tumor | 23 | 2025 | 3542 | 0.960 |
Why?
| | Biomarkers, Tumor | 6 | 2025 | 1321 | 0.810 |
Why?
| | Transcriptome | 8 | 2024 | 1038 | 0.800 |
Why?
| | Gene Regulatory Networks | 6 | 2023 | 317 | 0.770 |
Why?
| | Rectal Neoplasms | 2 | 2023 | 159 | 0.750 |
Why?
| | Neoplasms | 10 | 2025 | 2906 | 0.740 |
Why?
| | Crowdsourcing | 5 | 2023 | 18 | 0.710 |
Why?
| | Software | 3 | 2025 | 680 | 0.700 |
Why?
| | Computer Simulation | 5 | 2018 | 1003 | 0.690 |
Why?
| | Sarcoma | 1 | 2024 | 207 | 0.680 |
Why?
| | Hot Temperature | 1 | 2024 | 396 | 0.670 |
Why?
| | Breast Neoplasms | 8 | 2025 | 2382 | 0.660 |
Why?
| | Cell-Free Nucleic Acids | 1 | 2021 | 33 | 0.650 |
Why?
| | Premature Birth | 2 | 2023 | 388 | 0.650 |
Why?
| | Gene Expression Regulation, Neoplastic | 15 | 2025 | 1443 | 0.650 |
Why?
| | Neoadjuvant Therapy | 2 | 2020 | 465 | 0.640 |
Why?
| | Cholangiocarcinoma | 3 | 2025 | 108 | 0.590 |
Why?
| | Blood Proteins | 1 | 2021 | 239 | 0.590 |
Why?
| | Bile Duct Neoplasms | 3 | 2025 | 131 | 0.580 |
Why?
| | MutS Homolog 2 Protein | 1 | 2018 | 12 | 0.570 |
Why?
| | Genomics | 7 | 2024 | 825 | 0.570 |
Why?
| | Pre-Eclampsia | 1 | 2021 | 206 | 0.570 |
Why?
| | Pharmaceutical Preparations | 1 | 2020 | 170 | 0.570 |
Why?
| | Chromosomes, Human | 1 | 2018 | 44 | 0.560 |
Why?
| | Fluorescence | 1 | 2018 | 159 | 0.540 |
Why?
| | Tripartite Motif Proteins | 1 | 2017 | 39 | 0.520 |
Why?
| | Gestational Age | 1 | 2021 | 987 | 0.520 |
Why?
| | Humans | 75 | 2025 | 145474 | 0.520 |
Why?
| | Whole Genome Sequencing | 1 | 2018 | 177 | 0.520 |
Why?
| | Transcription Factors | 4 | 2022 | 1734 | 0.520 |
Why?
| | Metabolic Networks and Pathways | 1 | 2018 | 174 | 0.520 |
Why?
| | Models, Biological | 4 | 2018 | 1764 | 0.510 |
Why?
| | Genetic Loci | 1 | 2018 | 264 | 0.510 |
Why?
| | CRISPR-Cas Systems | 1 | 2018 | 166 | 0.500 |
Why?
| | Homeodomain Proteins | 5 | 2023 | 523 | 0.480 |
Why?
| | Body Mass Index | 1 | 2025 | 2445 | 0.470 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2017 | 192 | 0.470 |
Why?
| | Biomedical Research | 3 | 2025 | 717 | 0.460 |
Why?
| | Carcinoma, Pancreatic Ductal | 3 | 2025 | 293 | 0.460 |
Why?
| | Pancreatic Neoplasms | 4 | 2025 | 928 | 0.440 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 5 | 2023 | 1963 | 0.430 |
Why?
| | Telomerase | 4 | 2020 | 246 | 0.430 |
Why?
| | MAP Kinase Kinase Kinases | 3 | 2021 | 70 | 0.410 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 779 | 0.410 |
Why?
| | Triple Negative Breast Neoplasms | 3 | 2025 | 218 | 0.400 |
Why?
| | Neoplasm Recurrence, Local | 5 | 2025 | 1149 | 0.380 |
Why?
| | Lung Neoplasms | 4 | 2025 | 2664 | 0.380 |
Why?
| | Competitive Behavior | 1 | 2013 | 43 | 0.370 |
Why?
| | Oligonucleotide Array Sequence Analysis | 7 | 2016 | 749 | 0.370 |
Why?
| | Chromosomes, Human, Pair 21 | 2 | 2025 | 42 | 0.360 |
Why?
| | DNA-Binding Proteins | 6 | 2022 | 1480 | 0.360 |
Why?
| | Receptors, Androgen | 3 | 2021 | 148 | 0.360 |
Why?
| | Small Molecule Libraries | 2 | 2025 | 111 | 0.360 |
Why?
| | Animals | 34 | 2025 | 38030 | 0.360 |
Why?
| | Magnetic Resonance Imaging | 5 | 2025 | 3904 | 0.350 |
Why?
| | Carcinoma, Transitional Cell | 3 | 2017 | 68 | 0.340 |
Why?
| | Obesity | 1 | 2025 | 3116 | 0.330 |
Why?
| | Cooperative Behavior | 2 | 2016 | 462 | 0.330 |
Why?
| | Rhabdomyosarcoma | 2 | 2022 | 65 | 0.320 |
Why?
| | Drosophila | 3 | 2008 | 164 | 0.320 |
Why?
| | Mutation | 8 | 2025 | 4075 | 0.320 |
Why?
| | Neoplasm Metastasis | 7 | 2025 | 688 | 0.310 |
Why?
| | Cadherins | 3 | 2024 | 200 | 0.310 |
Why?
| | Radiosurgery | 2 | 2024 | 399 | 0.300 |
Why?
| | Protein Interaction Mapping | 1 | 2009 | 105 | 0.290 |
Why?
| | Mice | 21 | 2025 | 18329 | 0.280 |
Why?
| | Zebrafish Proteins | 2 | 2022 | 314 | 0.280 |
Why?
| | Protein Tyrosine Phosphatases | 2 | 2020 | 167 | 0.270 |
Why?
| | Aminopeptidases | 2 | 2024 | 20 | 0.260 |
Why?
| | Databases, Genetic | 3 | 2018 | 238 | 0.260 |
Why?
| | Drosophila melanogaster | 1 | 2009 | 237 | 0.260 |
Why?
| | Xenograft Model Antitumor Assays | 4 | 2024 | 934 | 0.260 |
Why?
| | DNA Helicases | 2 | 2021 | 136 | 0.250 |
Why?
| | Prostatic Neoplasms, Castration-Resistant | 2 | 2017 | 53 | 0.240 |
Why?
| | Adenocarcinoma | 2 | 2024 | 925 | 0.240 |
Why?
| | Eukaryotic Initiation Factor-3 | 1 | 2025 | 10 | 0.230 |
Why?
| | Signal Transduction | 8 | 2025 | 5216 | 0.230 |
Why?
| | Oncogene Proteins, Fusion | 3 | 2023 | 212 | 0.220 |
Why?
| | Promoter Regions, Genetic | 6 | 2021 | 1246 | 0.220 |
Why?
| | Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2025 | 39 | 0.220 |
Why?
| | Chemokine CCL2 | 1 | 2025 | 112 | 0.220 |
Why?
| | Meta-Analysis as Topic | 2 | 2023 | 171 | 0.210 |
Why?
| | Orthomyxoviridae Infections | 1 | 2025 | 71 | 0.210 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2021 | 219 | 0.210 |
Why?
| | Epigenesis, Genetic | 3 | 2020 | 679 | 0.210 |
Why?
| | ACTH-Secreting Pituitary Adenoma | 1 | 2024 | 12 | 0.210 |
Why?
| | Tomography, X-Ray Computed | 2 | 2025 | 2769 | 0.210 |
Why?
| | Female | 26 | 2025 | 78844 | 0.200 |
Why?
| | Cell Proliferation | 9 | 2025 | 2507 | 0.200 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2025 | 133 | 0.200 |
Why?
| | Datasets as Topic | 1 | 2023 | 118 | 0.190 |
Why?
| | Rectum | 2 | 2023 | 182 | 0.190 |
Why?
| | Endometrial Neoplasms | 1 | 2025 | 205 | 0.190 |
Why?
| | Protein Biosynthesis | 1 | 2025 | 452 | 0.190 |
Why?
| | Neuroendocrine Tumors | 1 | 2024 | 119 | 0.180 |
Why?
| | Proteomics | 3 | 2021 | 1188 | 0.180 |
Why?
| | Radiation Dosage | 1 | 2024 | 193 | 0.180 |
Why?
| | Nuclear Proteins | 2 | 2020 | 740 | 0.180 |
Why?
| | MDS1 and EVI1 Complex Locus Protein | 1 | 2022 | 8 | 0.180 |
Why?
| | Organoids | 1 | 2024 | 145 | 0.180 |
Why?
| | Sarcoma, Ewing | 1 | 2023 | 103 | 0.180 |
Why?
| | Melanoma | 2 | 2023 | 759 | 0.180 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2025 | 919 | 0.180 |
Why?
| | Molecular Targeted Therapy | 1 | 2025 | 439 | 0.180 |
Why?
| | Interleukin-13 Receptor alpha2 Subunit | 1 | 2021 | 5 | 0.170 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 480 | 0.170 |
Why?
| | Neoplasm Invasiveness | 3 | 2018 | 506 | 0.170 |
Why?
| | NF-kappa B | 1 | 2025 | 666 | 0.170 |
Why?
| | Indoles | 1 | 2025 | 507 | 0.170 |
Why?
| | ROC Curve | 2 | 2021 | 617 | 0.170 |
Why?
| | Muscle Development | 1 | 2022 | 112 | 0.170 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2023 | 223 | 0.170 |
Why?
| | ADAM10 Protein | 1 | 2021 | 29 | 0.170 |
Why?
| | Receptors, CCR2 | 1 | 2020 | 39 | 0.160 |
Why?
| | Asymptomatic Diseases | 1 | 2021 | 104 | 0.160 |
Why?
| | Gamma Rays | 1 | 2021 | 57 | 0.160 |
Why?
| | Gene Ontology | 1 | 2020 | 53 | 0.160 |
Why?
| | PAX3 Transcription Factor | 1 | 2020 | 17 | 0.160 |
Why?
| | Carcinoma, Lobular | 1 | 2021 | 56 | 0.160 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 1 | 2020 | 26 | 0.160 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2021 | 78 | 0.160 |
Why?
| | Machine Learning | 3 | 2025 | 587 | 0.160 |
Why?
| | Forkhead Box Protein O1 | 1 | 2020 | 35 | 0.160 |
Why?
| | Cytoreduction Surgical Procedures | 1 | 2020 | 69 | 0.150 |
Why?
| | Watchful Waiting | 1 | 2020 | 90 | 0.150 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 64 | 0.150 |
Why?
| | Wnt Signaling Pathway | 1 | 2022 | 211 | 0.150 |
Why?
| | Radiation Injuries | 1 | 2021 | 149 | 0.150 |
Why?
| | Receptors, Interferon | 1 | 2019 | 60 | 0.150 |
Why?
| | Homologous Recombination | 1 | 2019 | 37 | 0.150 |
Why?
| | RNA Interference | 1 | 2021 | 475 | 0.150 |
Why?
| | Discoidin Domain Receptor 2 | 1 | 2019 | 6 | 0.150 |
Why?
| | Cytokines | 2 | 2024 | 2067 | 0.150 |
Why?
| | Tumor Microenvironment | 2 | 2020 | 734 | 0.140 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2020 | 423 | 0.140 |
Why?
| | Kynurenine | 1 | 2019 | 114 | 0.140 |
Why?
| | Trisomy | 1 | 2019 | 78 | 0.140 |
Why?
| | Dasatinib | 1 | 2019 | 58 | 0.140 |
Why?
| | Cell Differentiation | 3 | 2022 | 2046 | 0.140 |
Why?
| | Immunotherapy | 2 | 2025 | 666 | 0.140 |
Why?
| | Microbiota | 2 | 2023 | 730 | 0.140 |
Why?
| | Chloroquine | 1 | 2018 | 54 | 0.140 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 67 | 0.140 |
Why?
| | Neoplasm Proteins | 2 | 2018 | 441 | 0.140 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 126 | 0.140 |
Why?
| | Molecular Conformation | 1 | 2018 | 141 | 0.140 |
Why?
| | Receptors, Estrogen | 1 | 2021 | 401 | 0.140 |
Why?
| | Fibrosis | 1 | 2021 | 559 | 0.140 |
Why?
| | Prognosis | 7 | 2021 | 4316 | 0.140 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3413 | 0.140 |
Why?
| | Macrolides | 1 | 2018 | 67 | 0.140 |
Why?
| | Neoplasms, Experimental | 1 | 2019 | 167 | 0.140 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 425 | 0.140 |
Why?
| | Monte Carlo Method | 1 | 2018 | 147 | 0.130 |
Why?
| | Lysosomes | 1 | 2018 | 131 | 0.130 |
Why?
| | Histone Code | 1 | 2017 | 39 | 0.130 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2020 | 280 | 0.130 |
Why?
| | Probability | 1 | 2018 | 307 | 0.130 |
Why?
| | Immunity, Cellular | 1 | 2019 | 274 | 0.130 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2020 | 456 | 0.130 |
Why?
| | Cell Cycle Proteins | 1 | 2021 | 630 | 0.130 |
Why?
| | Cell Death | 1 | 2018 | 382 | 0.120 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 265 | 0.120 |
Why?
| | Data Interpretation, Statistical | 2 | 2009 | 368 | 0.120 |
Why?
| | Histidine Kinase | 1 | 2016 | 34 | 0.120 |
Why?
| | CD24 Antigen | 1 | 2016 | 18 | 0.120 |
Why?
| | YY1 Transcription Factor | 1 | 2016 | 24 | 0.120 |
Why?
| | DNA Damage | 1 | 2019 | 437 | 0.120 |
Why?
| | Organizational Innovation | 2 | 2016 | 119 | 0.120 |
Why?
| | Urologic Neoplasms | 1 | 2016 | 31 | 0.120 |
Why?
| | Nomograms | 1 | 2016 | 59 | 0.120 |
Why?
| | Transcriptional Activation | 1 | 2018 | 372 | 0.120 |
Why?
| | B7-H1 Antigen | 1 | 2018 | 244 | 0.120 |
Why?
| | Sulfonamides | 1 | 2020 | 583 | 0.110 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 159 | 0.110 |
Why?
| | DNA Methylation | 2 | 2017 | 674 | 0.110 |
Why?
| | Deoxycytidine | 1 | 2017 | 220 | 0.110 |
Why?
| | Male | 12 | 2025 | 72842 | 0.110 |
Why?
| | Drug Delivery Systems | 1 | 2019 | 381 | 0.110 |
Why?
| | rho Guanine Nucleotide Dissociation Inhibitor beta | 1 | 2014 | 4 | 0.110 |
Why?
| | Up-Regulation | 1 | 2018 | 847 | 0.110 |
Why?
| | Genetic Heterogeneity | 1 | 2015 | 66 | 0.110 |
Why?
| | Bayes Theorem | 3 | 2023 | 420 | 0.110 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 591 | 0.110 |
Why?
| | Telomere Homeostasis | 1 | 2015 | 33 | 0.110 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 409 | 0.110 |
Why?
| | Alleles | 1 | 2017 | 894 | 0.110 |
Why?
| | Histone Demethylases | 1 | 2014 | 38 | 0.110 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2018 | 673 | 0.100 |
Why?
| | rho GTP-Binding Proteins | 1 | 2014 | 56 | 0.100 |
Why?
| | Survival Rate | 4 | 2021 | 2090 | 0.100 |
Why?
| | Membrane Proteins | 1 | 2021 | 1164 | 0.100 |
Why?
| | Ovarian Neoplasms | 1 | 2020 | 595 | 0.100 |
Why?
| | Models, Theoretical | 1 | 2017 | 558 | 0.100 |
Why?
| | Transcription, Genetic | 3 | 2017 | 1454 | 0.100 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2014 | 68 | 0.100 |
Why?
| | Ornithine Decarboxylase Inhibitors | 1 | 2013 | 5 | 0.100 |
Why?
| | Anabolic Agents | 1 | 2013 | 13 | 0.100 |
Why?
| | Phylogeny | 3 | 2023 | 917 | 0.100 |
Why?
| | Drug Synergism | 1 | 2014 | 354 | 0.100 |
Why?
| | Phenotype | 2 | 2020 | 3155 | 0.100 |
Why?
| | International Cooperation | 1 | 2014 | 197 | 0.100 |
Why?
| | Organ Sparing Treatments | 1 | 2013 | 37 | 0.100 |
Why?
| | Microsatellite Repeats | 1 | 2014 | 157 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2022 | 910 | 0.100 |
Why?
| | Epigenomics | 1 | 2014 | 114 | 0.100 |
Why?
| | Databases, Protein | 2 | 2014 | 88 | 0.100 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2953 | 0.100 |
Why?
| | High-Throughput Screening Assays | 1 | 2015 | 176 | 0.100 |
Why?
| | Neoplasm Staging | 3 | 2024 | 1471 | 0.100 |
Why?
| | Drug Combinations | 1 | 2014 | 396 | 0.100 |
Why?
| | Models, Molecular | 1 | 2018 | 1598 | 0.100 |
Why?
| | Arthritis, Rheumatoid | 1 | 2022 | 1180 | 0.100 |
Why?
| | Infant, Newborn | 2 | 2023 | 6447 | 0.100 |
Why?
| | Cluster Analysis | 2 | 2016 | 500 | 0.090 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2020 | 686 | 0.090 |
Why?
| | Superoxides | 1 | 2013 | 198 | 0.090 |
Why?
| | Prostate | 1 | 2013 | 158 | 0.090 |
Why?
| | Apoptosis | 3 | 2021 | 2440 | 0.090 |
Why?
| | Integrins | 2 | 2023 | 90 | 0.090 |
Why?
| | Models, Statistical | 1 | 2016 | 671 | 0.090 |
Why?
| | Community-Institutional Relations | 1 | 2013 | 100 | 0.090 |
Why?
| | Cyclin-Dependent Kinase 4 | 1 | 2012 | 53 | 0.090 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 321 | 0.090 |
Why?
| | Biomarkers | 2 | 2021 | 4295 | 0.090 |
Why?
| | Lung | 1 | 2025 | 4106 | 0.090 |
Why?
| | Brain Neoplasms | 1 | 2021 | 1329 | 0.090 |
Why?
| | Pregnancy | 2 | 2023 | 7202 | 0.090 |
Why?
| | Genome-Wide Association Study | 1 | 2018 | 1407 | 0.090 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 254 | 0.080 |
Why?
| | B-Lymphocytes | 2 | 2014 | 870 | 0.080 |
Why?
| | Genome, Insect | 2 | 2009 | 28 | 0.080 |
Why?
| | Alternative Splicing | 1 | 2013 | 247 | 0.080 |
Why?
| | Saccharomyces cerevisiae | 3 | 2012 | 573 | 0.080 |
Why?
| | MCF-7 Cells | 2 | 2021 | 133 | 0.080 |
Why?
| | Reactive Oxygen Species | 1 | 2013 | 611 | 0.080 |
Why?
| | Enzyme Inhibitors | 1 | 2013 | 820 | 0.080 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 5983 | 0.080 |
Why?
| | Treatment Outcome | 3 | 2020 | 11772 | 0.080 |
Why?
| | Horns | 1 | 2009 | 1 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 2378 | 0.080 |
Why?
| | Pseudogenes | 1 | 2009 | 20 | 0.080 |
Why?
| | Expressed Sequence Tags | 1 | 2009 | 43 | 0.080 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2012 | 337 | 0.080 |
Why?
| | Hematopoietic Stem Cells | 1 | 2013 | 435 | 0.080 |
Why?
| | Testosterone | 1 | 2013 | 416 | 0.080 |
Why?
| | Models, Genetic | 2 | 2009 | 524 | 0.080 |
Why?
| | Systems Integration | 1 | 2009 | 36 | 0.070 |
Why?
| | Coleoptera | 1 | 2009 | 27 | 0.070 |
Why?
| | Double-Blind Method | 2 | 2025 | 2062 | 0.070 |
Why?
| | Drug Discovery | 2 | 2022 | 153 | 0.070 |
Why?
| | Genes, Fungal | 1 | 2009 | 55 | 0.070 |
Why?
| | Inflammation | 1 | 2020 | 2878 | 0.070 |
Why?
| | Stem Cells | 1 | 2013 | 628 | 0.070 |
Why?
| | Tumor Cells, Cultured | 2 | 2021 | 886 | 0.070 |
Why?
| | Gene Deletion | 1 | 2009 | 391 | 0.070 |
Why?
| | Genetic Diseases, Inborn | 1 | 2008 | 45 | 0.070 |
Why?
| | Genes, Insect | 1 | 2007 | 22 | 0.070 |
Why?
| | Adult | 5 | 2025 | 40777 | 0.070 |
Why?
| | Combined Modality Therapy | 2 | 2020 | 1266 | 0.060 |
Why?
| | Disease | 1 | 2008 | 96 | 0.060 |
Why?
| | BRCA1 Protein | 2 | 2020 | 82 | 0.060 |
Why?
| | Zebrafish | 2 | 2022 | 532 | 0.060 |
Why?
| | Genome, Human | 1 | 2009 | 420 | 0.060 |
Why?
| | Genetics, Population | 1 | 2008 | 217 | 0.060 |
Why?
| | Aged | 6 | 2025 | 26153 | 0.060 |
Why?
| | Antigens, CD | 2 | 2024 | 558 | 0.060 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2025 | 1140 | 0.060 |
Why?
| | Mitochondria | 1 | 2013 | 992 | 0.060 |
Why?
| | Oxidative Stress | 1 | 2013 | 1356 | 0.060 |
Why?
| | Selection, Genetic | 1 | 2008 | 261 | 0.060 |
Why?
| | Prednisone | 2 | 2017 | 224 | 0.060 |
Why?
| | Theranostic Nanomedicine | 1 | 2025 | 15 | 0.060 |
Why?
| | Bile Ducts, Extrahepatic | 1 | 2025 | 20 | 0.060 |
Why?
| | Maintenance Chemotherapy | 1 | 2025 | 42 | 0.060 |
Why?
| | Chromatin | 2 | 2022 | 553 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2013 | 1996 | 0.050 |
Why?
| | Follow-Up Studies | 3 | 2020 | 5423 | 0.050 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2025 | 118 | 0.050 |
Why?
| | Cell Hypoxia | 1 | 2025 | 247 | 0.050 |
Why?
| | Cell Line | 3 | 2019 | 2823 | 0.050 |
Why?
| | Base Sequence | 3 | 2017 | 2170 | 0.050 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 2024 | 75 | 0.050 |
Why?
| | Evolution, Molecular | 1 | 2007 | 492 | 0.050 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2025 | 296 | 0.050 |
Why?
| | Cell Movement | 2 | 2021 | 959 | 0.050 |
Why?
| | Proto-Oncogene Protein c-fli-1 | 1 | 2023 | 30 | 0.050 |
Why?
| | RNA-Binding Protein EWS | 1 | 2023 | 31 | 0.050 |
Why?
| | BCG Vaccine | 1 | 2023 | 27 | 0.050 |
Why?
| | Chemokine CXCL9 | 1 | 2023 | 38 | 0.050 |
Why?
| | Cells, Cultured | 3 | 2016 | 4148 | 0.050 |
Why?
| | Internet | 1 | 2008 | 689 | 0.050 |
Why?
| | Mice, Nude | 2 | 2016 | 679 | 0.050 |
Why?
| | Protein Binding | 2 | 2020 | 2238 | 0.050 |
Why?
| | Biological Assay | 1 | 2023 | 130 | 0.050 |
Why?
| | Anti-Bacterial Agents | 1 | 2013 | 1923 | 0.050 |
Why?
| | Pituitary Neoplasms | 1 | 2024 | 190 | 0.050 |
Why?
| | Myogenin | 1 | 2022 | 15 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2024 | 412 | 0.040 |
Why?
| | Rhabdomyosarcoma, Embryonal | 1 | 2022 | 16 | 0.040 |
Why?
| | MyoD Protein | 1 | 2022 | 31 | 0.040 |
Why?
| | Proteins | 1 | 2008 | 1023 | 0.040 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2022 | 92 | 0.040 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2023 | 155 | 0.040 |
Why?
| | Adjuvants, Immunologic | 1 | 2023 | 243 | 0.040 |
Why?
| | Cell Lineage | 2 | 2013 | 377 | 0.040 |
Why?
| | Vagina | 1 | 2023 | 203 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2025 | 1132 | 0.040 |
Why?
| | Chondrogenesis | 1 | 2022 | 88 | 0.040 |
Why?
| | Phenylthiohydantoin | 1 | 2021 | 44 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2025 | 776 | 0.040 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2022 | 108 | 0.040 |
Why?
| | Wnt Proteins | 1 | 2022 | 133 | 0.040 |
Why?
| | Contrast Media | 1 | 2024 | 497 | 0.040 |
Why?
| | Neural Crest | 1 | 2022 | 129 | 0.040 |
Why?
| | Middle Aged | 5 | 2025 | 36215 | 0.040 |
Why?
| | Ephrin-B2 | 1 | 2021 | 45 | 0.040 |
Why?
| | Skull | 1 | 2022 | 162 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2022 | 3124 | 0.040 |
Why?
| | Precision Medicine | 1 | 2025 | 459 | 0.040 |
Why?
| | Tamoxifen | 1 | 2021 | 191 | 0.040 |
Why?
| | Cartilage | 1 | 2022 | 197 | 0.040 |
Why?
| | Breast | 1 | 2021 | 156 | 0.040 |
Why?
| | Melanoma, Experimental | 1 | 2020 | 109 | 0.040 |
Why?
| | Benzamides | 1 | 2021 | 226 | 0.040 |
Why?
| | Quinolinic Acid | 1 | 2019 | 7 | 0.040 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2020 | 139 | 0.040 |
Why?
| | Nitriles | 1 | 2021 | 207 | 0.040 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 24 | 0.040 |
Why?
| | beta Catenin | 1 | 2022 | 254 | 0.040 |
Why?
| | Androgens | 1 | 2021 | 181 | 0.040 |
Why?
| | Chondrocytes | 1 | 2022 | 232 | 0.040 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 56 | 0.040 |
Why?
| | Aged, 80 and over | 2 | 2025 | 8333 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 174 | 0.040 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 12 | 0.040 |
Why?
| | Enhancer Elements, Genetic | 1 | 2020 | 191 | 0.040 |
Why?
| | Inhibitor of Differentiation Proteins | 1 | 2018 | 2 | 0.040 |
Why?
| | Young Adult | 3 | 2024 | 14218 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2025 | 4560 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 369 | 0.030 |
Why?
| | Cell Cycle | 1 | 2021 | 598 | 0.030 |
Why?
| | 5-Methylcytosine | 1 | 2017 | 24 | 0.030 |
Why?
| | Enhancer of Zeste Homolog 2 Protein | 1 | 2017 | 55 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2020 | 442 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2020 | 969 | 0.030 |
Why?
| | CpG Islands | 1 | 2017 | 163 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1747 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 613 | 0.030 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2017 | 79 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2023 | 981 | 0.030 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2016 | 36 | 0.030 |
Why?
| | Taxoids | 1 | 2016 | 114 | 0.030 |
Why?
| | Co-Repressor Proteins | 1 | 2016 | 18 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2016 | 148 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1261 | 0.030 |
Why?
| | Chromosome Deletion | 1 | 2016 | 126 | 0.030 |
Why?
| | Heterografts | 1 | 2016 | 143 | 0.030 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 261 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 2134 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2016 | 184 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 333 | 0.030 |
Why?
| | rhoC GTP-Binding Protein | 1 | 2014 | 6 | 0.030 |
Why?
| | Sequence Analysis, DNA | 2 | 2008 | 777 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2016 | 2158 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 2016 | 506 | 0.030 |
Why?
| | Exome | 1 | 2016 | 227 | 0.030 |
Why?
| | Zinc Finger E-box Binding Homeobox 2 | 1 | 2014 | 6 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2016 | 200 | 0.030 |
Why?
| | Urothelium | 1 | 2015 | 33 | 0.030 |
Why?
| | Protein Domains | 1 | 2016 | 311 | 0.030 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2014 | 56 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1476 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2009 | 2883 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 1374 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2014 | 246 | 0.030 |
Why?
| | Sequence Analysis, Protein | 1 | 2014 | 32 | 0.030 |
Why?
| | Ornithine Decarboxylase | 1 | 2013 | 13 | 0.030 |
Why?
| | Follistatin | 1 | 2013 | 12 | 0.030 |
Why?
| | Eflornithine | 1 | 2013 | 8 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2023 | 2597 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 382 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2015 | 310 | 0.030 |
Why?
| | Point Mutation | 1 | 2015 | 240 | 0.030 |
Why?
| | Metabolomics | 1 | 2019 | 732 | 0.030 |
Why?
| | Intrinsically Disordered Proteins | 1 | 2014 | 42 | 0.030 |
Why?
| | Blotting, Western | 1 | 2016 | 1179 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2014 | 219 | 0.020 |
Why?
| | Protein Conformation | 1 | 2016 | 938 | 0.020 |
Why?
| | Aminoglycosides | 1 | 2013 | 30 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2015 | 762 | 0.020 |
Why?
| | Area Under Curve | 1 | 2014 | 331 | 0.020 |
Why?
| | beta-Lactams | 1 | 2013 | 32 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1041 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2016 | 530 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2016 | 454 | 0.020 |
Why?
| | Organ Size | 1 | 2013 | 461 | 0.020 |
Why?
| | Genes, ras | 1 | 2012 | 96 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2017 | 1061 | 0.020 |
Why?
| | Doxycycline | 1 | 2012 | 62 | 0.020 |
Why?
| | Databases, Factual | 1 | 2018 | 1490 | 0.020 |
Why?
| | Cell Cycle Checkpoints | 1 | 2012 | 97 | 0.020 |
Why?
| | Bone Marrow Transplantation | 1 | 2013 | 298 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 845 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2013 | 335 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2014 | 429 | 0.020 |
Why?
| | Benzimidazoles | 1 | 2012 | 189 | 0.020 |
Why?
| | DNA | 1 | 2017 | 1435 | 0.020 |
Why?
| | Quinolones | 1 | 2013 | 203 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2013 | 500 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2013 | 1368 | 0.020 |
Why?
| | Pupa | 1 | 2009 | 14 | 0.020 |
Why?
| | Body Weight | 1 | 2013 | 971 | 0.020 |
Why?
| | Gene Library | 1 | 2009 | 122 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1100 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2013 | 1716 | 0.020 |
Why?
| | Larva | 1 | 2009 | 240 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2188 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2012 | 451 | 0.020 |
Why?
| | Synteny | 1 | 2007 | 12 | 0.020 |
Why?
| | Escherichia coli | 1 | 2012 | 835 | 0.020 |
Why?
| | Gene Order | 1 | 2007 | 29 | 0.020 |
Why?
| | Genome, Mitochondrial | 1 | 2007 | 26 | 0.020 |
Why?
| | Adolescent | 2 | 2017 | 22529 | 0.020 |
Why?
| | Codon | 1 | 2007 | 92 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2864 | 0.020 |
Why?
| | Multigene Family | 1 | 2007 | 210 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2007 | 362 | 0.020 |
Why?
| | Immunity | 1 | 2007 | 140 | 0.020 |
Why?
| | DNA Transposable Elements | 1 | 2007 | 124 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2015 | 2803 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 10885 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 7123 | 0.020 |
Why?
| | RNA, Untranslated | 1 | 2007 | 121 | 0.010 |
Why?
| | Reproduction | 1 | 2007 | 208 | 0.010 |
Why?
| | Terminology as Topic | 1 | 2008 | 257 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2024 | 17291 | 0.010 |
Why?
| | Drosophila Proteins | 1 | 2007 | 213 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1789 | 0.010 |
Why?
| | Child | 1 | 2023 | 22707 | 0.010 |
Why?
| | RNA | 1 | 2008 | 910 | 0.010 |
Why?
|
|
Costello's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|